Wolverine Trading, LLC Galectin Therapeutics Inc Put Options Transaction History

Wolverine Trading, LLC

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$1.19 - $1.74 $2,380 - $3,480	-2,000 Reduced 9.85%	18,300 $23,000
Q1 2022 May 16, 2022	BUY	$1.61 - $2.31 $13,041 - $18,711	8,100 Added 66.39%	20,300 $35,000
Q4 2021 Feb 14, 2022	SELL	$2.07 - $3.8 $26,081 - $47,880	-12,600 Reduced 50.81%	12,200 $26,000
Q1 2021 May 14, 2021	BUY	$1.96 - $2.57 $16,464 - $21,588	8,400 Added 51.22%	24,800 $50,000
Q4 2019 Feb 12, 2020	SELL	$2.79 - $4.32 $837 - $1,296	-300 Reduced 1.8%	16,400 $46,000
Q3 2019 Nov 14, 2019	SELL	$3.0 - $4.05 $8,100 - $10,935	-2,700 Reduced 13.92%	16,700 $61,000
Q2 2019 Aug 20, 2019	SELL	$3.61 - $5.0 $57,760 - $80,000	-16,000 Reduced 45.2%	19,400 $81,000
Q1 2019 May 15, 2019	SELL	$3.86 - $6.02 $20,072 - $31,303	-5,200 Reduced 12.81%	35,400 $181,000
Q4 2018 Feb 14, 2019	BUY	$3.43 - $5.74 $36,701 - $61,418	10,700 Added 35.79%	40,600 $153,000
Q3 2018 Nov 14, 2018	BUY	$3.68 - $6.93 $27,968 - $52,668	7,600 Added 34.08%	29,900 $180,000
Q1 2018 May 15, 2018	BUY	$3.78 - $5.97 $84,294 - $133,131	22,300 New	22,300 $106,000
Q4 2017 Feb 14, 2018	SELL	$1.54 - $3.34 $21,868 - $47,428	-14,200 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$1.67 - $2.3 $23,714 - $32,659	14,200	14,200 $30,000

9.65M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $123M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.